Overview

PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment

Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to understand how Amisulpride is taken up and distributed around the body and how quickly it is eliminated, when given by mouth and into a vein in adults with severe kidney disease. In addition it is important to understand how well tolerated Amisulpride is in this patient population. Healthy adults will be studied to provide a comparison.
Phase:
Phase 1
Details
Lead Sponsor:
Acacia Pharma Ltd
Treatments:
Amisulpride